CRON Q4 2025 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q4 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$91M+201.3% YoY

Gross Profit

$16M17.7% margin

Operating Income

$7M7.6% margin

Net Income

-$2M-2.0% margin

EPS (Diluted)

$-0.00

QoQ Revenue Growth

+151.3%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$10M

Stock-Based Comp.

-$6M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$54M

Stockholders' Equity

$1.1B

Cash & Equivalents

$792M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91M	$30M	+201.3%
Gross Profit	$16M	$11M	+49.8%
Operating Income	$7M	-$11M	+161.3%
Net Income	-$2M	$44M	-104.2%

Revenue Segments

Cannabis Flower

$34M76%

Cannabis Extracts

$11M24%

Product and Service, Other

$18,0000%

Geographic Segments

CANADA

$28M63%

ISRAEL

$12M27%

Other Countries

$5M11%